男友太凶猛1v1高h,大地资源在线资源免费观看 ,人妻少妇精品视频二区,极度sm残忍bdsm变态

US EUROPE AFRICA ASIA 中文
Business / Companies

Guilin at forefront in battle against malaria

By Wang Hongyi (China Daily) Updated: 2015-11-09 09:47

Since 2000, global mortality rates among malaria patients have dropped by 47 percent. In Africa, the rate has come down by 54 percent for adults and 58 percent for children.

GPSC has played an important role, along with major global pharmaceutical companies such as Novartis in Switzerland and Sanofi-Aventis in France, in fighting malaria.

The Chinese company was at the forefront in developing the innovative artesunate vaccine, Artsun, the first of its kind, to replace quinine injections. The WHO has compared it to the "gold standard" in the battle against malaria.

Artsun is now registered in more than 30 countries and regions and has a 90 percent market share in treating servere malaria.

During the past three years, GPSC has supplied 23.8 million units of the vaccine globally, saving more than 3.4 million people from the scourge of malaria.

"This is an innovative drug that was developed in China," Guo Guangchang, chairman of Fosun Group, said.

During the past decade, 13 anti-malaria drugs developed by GPSC have been approved by the WHO, including three which are injected and 10 in oral tablets.

The company's products account for 80 percent of China's anti-malaria drug exports.

In the first three quarters of this year, Fosun Pharmaceutical, which includes GPSC, reported revenue of 9 billion yuan ($1.41 billion), a rise of 4.76 percent compared to the same period in 2014.

Further financial details have yet to be released. The company's products include metabolism and digestive system drugs, and vaccines, as well as GPSC's brands.

"At present, Guilin Pharma is building a new manufacturing site which will comply with (international) standards," GPSC said.

"In future, we will have a production capacity of over 15 billion tablets/capsules per year to meet the needs of both domestic and global markets." the company added.

Fosun Pharmaceutical also plans to expand its research and development program by working alongside institutions and other organizations.

"There should be more cooperation with research institutes and organizations," Chen Qiyu, chairman of Fosun Pharmaceutical, said.

"This would help create a much larger platform, allowing us to do a better job globally."

Previous Page 1 2 Next Page

Hot Topics

Editor's Picks
...
主站蜘蛛池模板: 乐业县| 孙吴县| 通化县| 镇赉县| 齐齐哈尔市| 海丰县| 白水县| 伊金霍洛旗| 盱眙县| 平定县| 横峰县| 内黄县| 开封市| 庐江县| 同江市| 大厂| 兰州市| 大竹县| 寻甸| 子长县| 香港 | 永泰县| 绥芬河市| 贡山| 黔江区| 安庆市| 正阳县| 宝应县| 玉溪市| 罗田县| 昌图县| 秦安县| 英山县| 疏附县| 安阳市| 金塔县| 肇源县| 定结县| 司法| 长顺县| 肇东市|